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protein is uniquely expressed in highly select bronchial 
epithelial cells and submucosal glands in naive mice, con-
sistent with anatomical locations of progenitor cell niches. 
Under conditions of challenge (PBS, S. aureus, S. pneu-
moniae, influenza virus), mRNA and protein expression 
strongly declined with protein recovery only in models 
retaining intact epithelial cells. In contrast to mice, human 
and porcine bronchial epithelial cells do not express their 
respective mCLCA5 orthologs and submucosal glands had 
fewer expressing cells, indicative of fundamental differ-
ences in mice versus humans and pigs.
Keywords Airway epithelial cell · Murine lung · 
mCLCA3 · Mucus cell metaplasia · Translational medicine
Introduction
mCLCA5 is a murine member of the chloride channel reg-
ulators, calcium-activated (CLCA) protein family which 
has been linked to inflammatory airway diseases with 
increased mucus production such as asthma, cystic fibro-
sis and chronic obstructive pulmonary disease (Brouillard 
et al. 2005; Hegab et al. 2004; Kamada et al. 2004). It has 
also been hypothesized that CLCA proteins act as extracel-
lular signaling molecules, transforming airway mucus pre-
cursor cells to mature mucus cells (Patel et al. 2009) or, as 
growing evidence suggests, modulating the innate immune 
response (Dietert et al. 2014; Long et al. 2006; Zhang and 
He 2010), pointing toward a pleiotropic function of these 
proteins (Patel et al. 2009).
The human CLCA1 (hCLCA1), expressed in mucus 
cells of the respiratory tract (Gibson et al. 2005), is known 
to regulate mucus cell metaplasia by inducing mucus gene 
transcription via a downstream mitogen-activated protein 
Abstract The murine mCLCA5 protein is a member of 
the chloride channel regulators, calcium-activated (CLCA) 
family and is suspected to play a role in airway mucus cell 
differentiation. Although mCLCA5 mRNA was previously 
found in total lung extracts, the expressing cells and func-
tions in the naive murine respiratory tract are unknown. 
Therefore, mCLCA5 protein expression was identified by 
immunohistochemistry and confocal laser scanning micros-
copy using entire lung sections of naive mice. Moreover, 
we determined mRNA levels of functionally related genes 
(mClca3, mClca5, Muc5ac and Muc5b) and quantified 
mCLCA5-, mCLCA3- and CC10-positive cells and peri-
odic acid-Schiff-positive mucus cells in naive, PBS-treated 
or Staphylococcus aureus-infected mice. We also investi-
gated mCLCA5 protein expression in Streptococcus pneu-
moniae and influenza virus lung infection models. Finally, 
we determined species-specific differences in the expres-
sion patterns of the murine mCLCA5 and its human and 
porcine orthologs, hCLCA2 and pCLCA2. The mCLCA5 
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kinase (MAPK)-13 signaling pathway (Alevy et al. 2012). 
In the mouse lung, overexpression of mCLCA3, the murine 
ortholog of hCLCA1, also induces mucus cell metapla-
sia; however, mClca3 knockout mice do not show a corre-
sponding phenotype (Patel et al. 2006). Loss of mCLCA3 
in these mice has been discussed to be compensated by 
increased mCLCA5 expression in experimentally induced 
mucus cell metaplasia in vitro and in vivo (Alevy et al. 
2012; Mundhenk et al. 2012; Patel et al. 2006). It has con-
sequently been speculated that the two proteins may have 
a redundant function in the respiratory tract, which is also 
supported by the observation that gene transfer with a vec-
tor-encoding mClca5 also induces airway mucus produc-
tion (Patel et al. 2006).
Interestingly, mCLCA5 mRNA has been detected in 
various tissues, including the respiratory tract of naive 
mice in which neither its expressing cell type nor its pro-
tein has been observed so far (Braun et al. 2010). Instead, 
mCLCA5 protein was only discovered after Th2-induced 
airway inflammation (Mundhenk et al. 2012). In unchal-
lenged mice, the protein has only been detected outside the 
respiratory tract, specifically in late differentiated keratino-
cytes of all stratified squamous epithelial granular layers 
throughout the body with a proposed function in growth 
arrest and maturation of squamous epithelial cells (Braun 
et al. 2010). In contrast to mCLCA5, the human ortholo-
gous hCLCA2 protein appears to be expressed in basal epi-
thelial cells of stratified epithelia, with a proposed role in 
stratification and basal cell-basement membrane adhesion 
(Carter et al. 1990; Connon et al. 2004, 2005). However, 
it has never been detected in airway epithelial cells and, in 
contrast to the murine mCLCA5, is not overexpressed fol-
lowing induction of mucus cell metaplasia (Alevy et al. 
2012). It has been argued that due to these differences 
between murine and human CLCA orthologs, the value of 
mouse models for mucus cell metaplasia in translational 
medicine is questionable. Functional studies on mucus cell 
differentiation are still lacking, but it has been shown that 
the expression pattern of pCLCA1, the porcine ortholog to 
hCLCA1 and to mCLCA3, is virtually identical with that 
of hCLCA1, supporting the pig as the favored translational 
model (Plog et al. 2009).
Porcine pCLCA2, the ortholog of hCLCA2 and 
mCLCA5, is also expressed in airways on mRNA level, 
but the expressing cell type is still unknown (Plog et al. 
2012b). Similarly to mCLCA5, its protein has, so far, only 
been found in mature keratinocytes of the epidermis and in 
the inner root sheath of hair follicles (Plog et al. 2012b).
We hypothesized that mCLCA5 protein is expressed in 
highly select areas of the naive murine lung, since it has 
only been found on the mRNA level in total lung extracts 
so far. We further speculated that its expression pattern may 
be different from that of human and porcine orthologs since 
the expressional behaviors differ between the murine and 
the human orthologs following induction of mucus cell 
metaplasia (Alevy et al. 2012).
Consequently, we systematically characterized the 
protein expression pattern of mCLCA5 on entire mouse 
lung sections by immunohistochemistry and localized the 
protein by confocal laser scanning immunofluorescence 
microscopy and immunohistochemical double staining for 
specific cell markers. Since growing evidence addition-
ally suggests a modulating role of CLCA proteins in innate 
immune response (Dietert et al. 2014; Long et al. 2006; 
Zhang and He 2010), we determined lung mRNA expres-
sion levels of selected genes of interest, including mClca3, 
mClca5, Muc5ac and Muc5b and quantified cells express-
ing mCLCA5, mCLCA3 and club (formerly Clara) cell 
protein CC10 as well as periodic acid-Schiff (PAS)-positive 
mucus cells from PBS-treated or Staphylococcus aureus (S. 
aureus)-infected mice in comparison with naive controls. 
We further investigated the course of mCLCA5 protein 
expression in two other lung infection models, Streptococ-
cus pneumoniae (S. pneumoniae) and influenza virus. To 
determine possible species-specific differences, we com-
pared the expression pattern of murine mCLCA5 with 
those of its human and porcine orthologs, hCLCA2 and 
pCLCA2.
Materials and methods
Naive mice and tissue processing
Naive female C57BL/6J wild-type mice, aged 8–9 weeks 
and weighing 18–20 g, were housed in individually ven-
tilated cages under SPF conditions with a room tempera-
ture of 22 ± 2 °C and a relative humidity of 45–65 %. A 
12-h light/dark cycle was maintained, and the animals had 
unlimited access to standard pelleted food and tap water. 
For experimental procedures, mice were anesthetized each 
by intraperitoneal injection of premixed ketamine (3.2 mg) 
and xylazine (1.5 mg) and sacrificed by exsanguination via 
the caudal Vena cava.
For lung tissue processing, whole lungs with tracheas 
were carefully removed, immersion fixed in 4 % formalin, 
pH 7.0, for up to 48 h, and subsequently embedded in par-
affin. Multiple sections were cut from serial levels of the 
lung to ensure that the trachea and the complete bronchial 
stem including its branching points were available for sys-
tematic investigation.
Lung tissue of mouse models, pigs and humans
Similarly processed, formalin-fixed and paraffin-embedded 
(FFPE) lung tissues or snap-frozen lungs from PBS-treated, 
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S. aureus-, S. pneumoniae- or influenza virus-infected mice 
from previous studies (Dames et al. 2014; Dietert et al. 
2014; Reppe et al. 2009) were used. Samples from human 
tracheas and lungs, obtained from body donors corpses at 
the Institute of Anatomy and Cell Biology, Justus-Liebig 
University, Giessen, Germany, as well as from healthy por-
cine tracheas and lungs, taken from the routine necropsy 
pool of the Department of Veterinary Pathology, Freie Uni-
versität Berlin, Germany, were also fixed in 4 % buffered 
formalin and embedded in paraffin.
RNA isolation and quantitative RT-PCR
Total RNA was isolated from snap-frozen, murine lungs 
using the Nucleo Spin RNA/Protein isolation Kit (Mach-
erey–Nagel, Düren, Germany), quality checked and quan-
tified using the NanoDrop ND-100 Spectrophotometer 
(Peqlab, Wilmington, USA). Transcript expression levels 
of murine Clca3, Clca5, Muc5ac and Muc5b, normalized 
to the reference genes elongation factor 1α (Ef-1α), β-2 
microglobulin (B2m) and glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh), were determined as described 
(Dietert et al. 2014). RT-qPCR and data analyses were con-
ducted using the CFX96 Touch Real-Time PCR Detection 
System and CFX Manager software 1.6 (BioRad). Relative 
quantification and comparison of groups were performed 
by the ΔΔCt method using naive animals as controls.
Histochemistry, immunohistochemistry and quantification 
of cells
For visualization of mucus cells, sections were processed 
as described and the PAS reaction was conducted (Lev-
erkoehne and Gruber 2002). Immunohistochemical analy-
ses were performed as described (Braun et al. 2010; Lev-
erkoehne and Gruber 2002). Briefly, entire murine FFPE 
lungs with tracheas or FFPE tissue samples from humans 
and pigs were cut at 2 µm thickness and mounted on adhe-
sive glass slides. After dewaxing in xylene and rehydra-
tion in decreasing ethanol concentrations, antigen retrieval 
was performed with 0.1 % protease pretreatment for 
10 min at 37 °C (AppliChem, Darmstadt) for the detec-
tion of mCLCA5, mCLCA3 or club cell protein 10 and 
with microwave heating (600 W) in 10-mM citric acid 
(750 ml, pH 6.0) for 12 min for the detection of cytokeratin 
5. For single stainings, slides of murine lungs were incu-
bated with immunopurified rabbit antibodies for mCLCA5 
(α-mCLCA5-C1-ap, 1:300) (Braun et al. 2010), mCLCA3 
(α-m3-C-1p, 1:600) (Bothe et al. 2011) or cytokeratin 5 
(1:1,000; ab24647, Abcam) or with the immunopurified 
goat antibody for club cell 10 protein (CC10, 1:1,500; 
sc-9772, Santa Cruz Biotechnology). To exclude cross-
reactivity of the mCLCA5 antibody with other murine 
CLCA members, immunohistochemical stainings of the 
intestine, expressing mCLCA3, mCLCA4, mCLCA6 and 
mCLCA7 (Patel et al. 2009), and the pancreas, express-
ing mCLCA1/2 (Roussa et al. 2010), were performed and 
yielded negative results. Furthermore, specificity of the 
mCLCA5 antibody was previously verified by immunoblot 
analysis (Braun et al. 2010). Slides of porcine lungs were 
incubated with the immunopurified rabbit antibody for 
pCLCA2 (p2-C-1a, 1:300) (Plog et al. 2012b). The human 
lung sections were incubated at 4 °C over night with the 
pCLCA2 antibody which yielded an identical, specific, cel-
lular staining pattern, pointing toward cross-reactivity with 
the human hCLCA2. Incubation with an immunopurified, 
irrelevant rabbit or goat antibody at similar dilutions served 
as negative control for all immunohistochemical stainings 
on murine, porcine and human tissue samples. The slides 
were incubated with biotinylated, secondary goat anti-rab-
bit IgG (1:200, BA 1000, Vector, Burlingame, CA) or rabbit 
anti-goat IgG (1:200, BA 5000, Vector, Burlingame, CA) 
antibodies and HRP- or AP-coupled streptavidin. Diam-
inobenzidine (DAB) or triamino-tritolyl-methanechloride 
(Neufuchsin) was used as substrates for color development, 
respectively. The slides were counterstained with hematox-
ylin or PAS reaction where indicated, dehydrated through 
graded ethanol, cleared in xylene and coverslipped.
Immunohistochemical double staining of mCLCA5 and 
mCLCA3 was performed using the H2O-elution method 
in accordance with the instructions of zytomed systems 
(Zytomed 2009). This method is suitable for double staining 
using primary antibodies from the same species. Therefore, 
slides were prepared as described above and incubated with 
the mCLCA5 antibody (1:300) at 4 °C over night. After 
incubation with the biotinylated, secondary goat anti-rabbit 
IgG antibody (1:200), DAB was used for color develop-
ment. Due to using two secondary antibodies against the 
same species, unspecific binding was excluded by washing 
the slides in heated, deionized water (750 ml microwaved 
at 600 W for 10 min) to eliminate remaining unbound pri-
mary antibodies with a consecutive rinse in water at 4 °C 
for 5 min. Following incubation with the purified mCLCA3 
antibody (1:600) at 4 °C over night and with the secondary, 
goat anti-rabbit IgG alkaline phosphatase-conjugated anti-
body (1:500, AP-1000, Vector, Burlingame, CA), triamino-
tritolyl-methanechloride (Neufuchsin) was used as substrate 
for color development. Slides that were incubated with an 
irrelevant immunopurified rabbit antibody served as nega-
tive controls. To ensure specific binding of the secondary 
either HRP- or AP-conjugated antibody with the mCLCA5- 
or mCLCA3-specific primary antibody, respectively, slides 
were incubated with only one primary but with both sec-
ondary antibodies. Finally, slides were counterstained 
with hematoxylin, dehydrated, cleared and coverslipped. 
PAS-, mCLCA5-, mCLCA3- and CC10-positive cells were 
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counted per millimeter of basement membrane at four ana-
tomically defined regions of the bronchial epithelium at the 
extra- to intrapulmonary junction (Fig. 1, black lines) of 
naive, PBS-treated or S. aureus-infected mice using digital 
image software (AnalySIS docu 5.0., SIS).
Immunofluorescence and spectral confocal laser scanning 
microscopy
For immunofluorescence co-localization analyses, slides 
were incubated with the purified, primary mCLCA5 
antibody (1:50) over night at 4 °C as described above and 
with Alexa Fluor 488-conjugated, secondary donkey anti-
rabbit IgG antibody (1:2,000, Invitrogen) for 1 h at room 
temperature. Slides were then incubated with the purified, 
primary CC10 antibody (1:50) at 4 °C over night, incu-
bated with Alexa Fluor 594-conjugated, secondary don-
key anti-goat IgG antibody (1:2,000, Invitrogen) for 1 h 
at room temperature and mounted with Roti-Mount Fluor-
Care DAPI (4,6-diaminidino-2-phenylindole) (Carl Roth, 
Karlsruhe, Germany). Adequate negative controls, includ-
ing incubation of slides with only one primary but both sec-
ondary antibodies, were conducted. Slides were analyzed 
by spectral confocal microscopy with a LSM 780 micro-
scope (objective 40×, Plan-Neofluar/oil, NA 1.3; Zeiss, 
Jena, Germany).
Data analysis
Data are expressed as mean ± SEM. Statistical analyses 
were performed using the Mann–Whitney test. p < 0.05 
was considered significant.
Results
mCLCA5 is expressed in select bronchial epithelial cells 
at the transition from the extrapulmonary main bronchi 
to the intrapulmonary bronchi
For systematic expression analyses of mCLCA5 in the 
naive murine respiratory tract, trachea and entire lungs 
including bronchial stem and its branching points were 
investigated (Fig. 1a). The mCLCA5 protein was exclu-
sively localized in bronchial epithelial cells of a defined 
region of approximately 2 mm in length (black lines) at 
the extra- to intrapulmonary junction as well as in epi-
thelial cells of the SMGs which are, in mice, restricted to 
the larynx and the proximal trachea. For quantification of 
the different cell types of the bronchial epithelium in this 
specific region, the numbers of mCLCA5-, mCLCA3-, 
CC10-positive cells as well as PAS-positive mucus cells 
per millimeter of basement membrane were determined 
(Fig. 1b). In this specific location, 70.9 ± 2.7 % of the 
bronchial epithelial cells were positive for the club cell 
marker CC10, followed by 51.5 ± 1.7 % of mCLCA5-
positive cells, 23.2 ± 3.2 % of PAS-positive cells and 
20.5 ± 2.9 % of mCLCA3-positive cells (mean ± SEM, 
n = 4). Cytokeratin 5 expressing basal cells was localized 
only in the tracheal epithelium as well as in the cartilagi-
nous bronchial epithelium and was clearly absent from 
the regions that possess mCLCA5-expressing cells (data 
not shown).
Fig. 1  mCLCA5 is expressed in lungs of naive mice in a highly 
selective pattern. a Whole lungs of naive mice were embedded in par-
affin, and multiple sections of defined layers were prepared to ensure 
that the entire bronchial stem and its branching points are available 
for systematic investigation. mCLCA5 protein is expressed in bron-
chial epithelial cells at the transition from the extrapulmonary main 
bronchi to the intrapulmonary bronchi (black lines) only. HE staining. 
b This region was characterized by CC10-positive club cells, PAS-
positive mucus cells as well as mCLCA5- and mCLCA3-expressing 
cells. Bar (a) 2 mm, bar (b) 20 µm
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mCLCA5 is predominantly located in club cells and, 
to a lesser extent, in ciliated cells and mucus cells of the 
bronchial epithelium, with a cell type-specific, subcellular 
expression pattern
For identification of mCLCA5-expressing cells, immu-
nofluorescence and spectral confocal laser scanning 
microscopy was performed. mCLCA5 was predominantly 
expressed in CC10-positive club cells (Fig. 2a, arrow) with 
a diffuse, either finely or coarsely granular, cytoplasmic 
pattern. However, only a limited number of club cells were 
positive for mCLCA5 protein expression. The protein was 
also detected in a few ciliated cells (Fig. 2a, arrowhead), 
displaying a clumpy and perinuclear expression signal. 
Further co-localization studies revealed mCLCA5 expres-
sion in few mucus cells (Fig. 2b, arrowhead), occasionally 
co-localized with the mucus cell marker mCLCA3 (Fig. 2c, 
arrowhead, d).
mCLCA5 mRNA and protein strongly decrease 
after various challenges
mRNA levels of Muc5ac, Muc5b, mClca3 and mClca5 
were quantified in lungs from naive, PBS-treated and S. 
aureus-infected mice by RTq-PCR. After 24 h, expres-
sion of both the mucin genes Muc5ac and Muc5b as well 
as of mClca3 was not altered compared to naive con-
trols, independently of the type of challenge (Fig. 3a, 
Fig. 2  mCLCA5 is predominantly located in club cells, to lesser 
extent in mucus cells and ciliated cells. a For co-localization stud-
ies of mCLCA5 and club cell protein CC10, immunofluorescence 
and spectral confocal laser scanning microscopy was performed. 
(mCLCA5: left, green; CC10: center, red; merged image: right). Blue 
DAPI (4,6-diaminidino-2-phenylindole) staining of the DNA in the 
nuclei. b, c Double staining of mCLCA5 either with PAS reaction, 
identifying mucus cells, or with mCLCA3 by immunohistochemistry 
was conducted. mCLCA5 is primarily located in club cells (a arrow), 
followed by fewer ciliated cells (a arrowhead) and mucus cells (b 
arrowhead). In mucus cells, mCLCA5 was occasionally co-localized 
with mCLCA3 (c arrowhead). d Club cells and mucus cells showed 
an either fine or coarse, diffuse, granular, cytoplasmatic, subcellular 
labeling pattern of mCLCA5, in contrast to ciliated cells, which dis-
played a clumpy and perinuclear labeling pattern. However, only a 
limited number of the investigated cells were positive for mCLCA5 
protein expression. Bar (a) 5 µm, bar (b, c) 10 µm
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b). Only mClca5 was significantly decreased on mRNA 
level after PBS treatment and S. aureus infection 
(Fig. 3c). Quantification of CC10-, PAS- and mCLCA3-
positive cells per mm basement membrane revealed no 
differences between PBS-treated or S. aureus-infected 
mice compared to naive controls at all time points inves-
tigated (Fig. 3d, e). In contrast, mCLCA5-positive cells 
were significantly reduced 24 h after PBS treatment and 
S. aureus infection compared to naive mice (Figs. 3d, 
4a, b). Despite this significant decrease which was still 
present after 48 h, the epithelium showed a slight ten-
dency toward increasing numbers of mCLCA5-positive 
cells (Figs. 3e, 4b) which were significantly elevated 
(*p < 0.05) in S. aureus-infected mice. Additionally, 
after infection of mice with S. pneumoniae (Fig. 4c) or 
influenza virus, which both caused significant cell dam-
age and loss in this area (Fig. 4d), a gradual reduction of 
mCLCA5-positive cells was observed over time without 
returning, possibly due to the initiated epithelial damage 
by these two pathogens.
Human and porcine mCLCA5 orthologs are expressed 
in submucosal glands but not in bronchial epithelial cells
In order to determine possible species-specific differences as 
seen for other CLCA gene family members, the respiratory 
expression patterns of the mCLCA5 orthologs, hCLCA2 and 
pCLCA2, were immunohistochemically examined in human 
or porcine lungs, respectively. In mice, SMGs are only present 
in the upper part of the trachea (Fig. 5a, blue lines), whereas 
in the human and porcine respiratory tracts, these glands 
line the entire cartilaginous airways down to their branching 
into segmental bronchi (Fig. 5b, c, blue lines). The epithe-
lial cells of these species-specifically distributed submucosal 
glands were positive for the respective CLCA orthologs in 
mice, humans and pigs in which the murine mCLCA5 signal 
was much stronger than in those of the respective orthologs 
(Fig. 5d–f, left picture). In contrast to the murine mCLCA5, 
neither its human nor its porcine ortholog was expressed in 
bronchial epithelial cells or other cell types throughout the 
entire lungs (Fig. 5d–f, right picture).
Fig. 3  mCLCA5 mRNA and protein are strongly decreased in chal-
lenged lungs. a–c 24 h after mice were treated with PBS or infected 
with S. aureus, lung mRNA expression levels of Muc5ac, Muc5b, 
mClca3 and mClca5 were determined by RT-qPCR in comparison 
with naive mice. Only mClca5 mRNA was significantly decreased 
in both challenge models (c). Dotted lines indicate fold changes of 
0.5 and 2, respectively, as limits for valid statement of lowered and 
elevated parameters. Values are given as mean ± SEM (n = 8 each 
group). Ct cycle threshold. *p < 0.05 versus the naive control group. 
d, e Numbers of CC10-, PAS-, mCLCA3- and mCLCA5-positive 
cells per mm basement membrane were quantified by immunohisto-
chemistry or PAS reaction. mCLCA5-positive cells were significantly 
reduced in both challenge models at indicated time points, without 
any further changes in number or composition of the bronchial epi-
thelial cells. Values are given as mean ± SEM (n = 4 each group). 
*p < 0.05 versus the naive control group
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Discussion
In the current study, we identified a unique mCLCA5 
expression pattern in mouse airways which is restricted 
to two specific locations. On the one hand, mCLCA5 is 
expressed in the epithelial cells of the SMGs and, on the 
other hand, in the bronchial epithelium, specifically at the 
transition of the extrapulmonary main bronchi into the 
intrapulmonary bronchi. Interestingly, both regions are 
anatomically described as progenitor cell niches which 
have been characterized by several studies in detail (Liu 
and Engelhardt 2008; Rawlins and Hogan 2006; Roomans 
2010; Warburton et al. 2008).
Club cells were the predominant cell type in the bron-
chial epithelia intensely expressing mCLCA5, whereas 
mucus cells and ciliated cells showed a reduced or absent 
expression of the mCLCA5 protein. Based on this appar-
ently unique and highly specific distribution pattern of 
the mCLCA5 protein in airway epithelial cells, we can 
virtually exclude mCLCA5 protein expression in other 
known select, functionally distinctive airway epithelial 
cells with a characteristic tissue distribution. In particu-
lar, basal cells in the tracheal and cartilaginous bronchial 
epithelium as well as club cells located more distally from 
this location, and alveolar epithelial cells type II clearly 
do not express mCLCA5. In particular, a specific subset 
of club cells, the variant club cell type, which is primar-
ily located in the non-cartilaginous bronchi and bronchi-
oles (Liu and Engelhardt 2008; Rawlins and Hogan 2006; 
Roomans 2010; Warburton et al. 2008), is a known progen-
itor cell for non-ciliated club cells, ciliated cells and mucus 
cells (Pardo-Saganta et al. 2013; Rawlins and Hogan 2006; 
Rawlins et al. 2009; Reader et al. 2003; Reynolds and Mal-
kinson 2010; Roomans 2010; Wong et al. 2009). A previ-
ous study identified mCLCA5 as being sufficient to induce 
mucus production and responsible for mucus cell metapla-
sia (Patel et al. 2009). Thus, the predominant expression 
of mCLCA5 in club cells as putative progenitors of mucus 
Fig. 4  mCLCA5 protein 
expression disappeared in 
various challenge models. 
Lungs from naive (n = 4) and 
PBS-treated (n = 4) mice as 
well as from mice infected with 
S. aureus (n = 4), S. pneumo-
niae (n = 2) and influenza virus 
(n = 2) were examined at the 
extrapulmonary to intrapulmo-
nary junction to characterize 
the presence and the course of 
mCLCA5 protein expression in 
this specific location at various 
time points. a, b Comparison of 
naive lungs to lungs from PBS-
treated or S. aureus-infected 
mice revealed a significant 
reduction in mCLCA5 protein 
expression 24 h after infection, 
with a slight tendency toward 
a return after 48 h. c, d After 
infection with S. pneumoniae 
and influenza virus, the immu-
nosignal of mCLCA5 disap-
peared over time. Bar 20 µm
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cells and its presence in known anatomical locations of 
progenitor cell niches would be in line with its proposed 
function in mucus cell differentiation. It is conceivable that 
mCLCA5 expression by precursor mucus cells drives their 
differentiation into mature mucus cells, as it has already 
been hypothesized for the closely related proteins hCLCA1 
and mCLCA3 (Alevy et al. 2012; Patel et al. 2006, 2009). 
These findings were confirmed by the fact that a role in 
epithelial differentiation of other lineages has already been 
shown for several CLCA members (Alevy et al. 2012; Patel 
et al. 2006, 2009; Walia et al. 2012; Yu et al. 2013) and 
is also consistent with the suspected role of mCLCA5 in 
growth arrest and maturation processes of squamous epi-
thelial cells of the skin (Beckley et al. 2004; Braun et al. 
2010). The identified expressing cell types showed a dis-
tinct intracellular mCLCA5 protein distribution pattern. In 
club cells and in the few mucus cells, mCLCA5 displayed a 
diffuse, finely granular, cytoplasmatic pattern as well as an 
evenly distributed but coarse and clumpy pattern through-
out the entire cytoplasm. In ciliated bronchial cells, a large, 
clumpy, perinuclear pattern dominated, suggesting that the 
subcellular protein distribution may depend on the differ-
entiation status of the respective cell type or on a cell type-
specific arrangement of organelles. Moreover, it is well 
conceivable that the mCLCA5 protein in mucus cells and 
ciliated cells is lost with progressing differentiation from 
airway precursor to mature cells.
Similar to mCLCA5, the murine mCLCA3 is a known 
inducer of mucus cell metaplasia (Patel et al. 2006) and it 
has been suspected that mCLCA5 and mCLCA3 may have 
redundant functions, with one compensating for the loss of 
the other (Patel et al. 2006, 2009). In our study, mCLCA5 
and mCLCA3 had only partially overlapping expres-
sion patterns in mucus cells and mCLCA3 was neither 
expressed in club cells nor in ciliated cells (Leverkoehne 
and Gruber 2002). This may be suggestive of different 
functional relevance of these two related proteins in their 
respective cellular microenvironments.
Expression of mCLCA5 was further characterized in 
lung tissues that were available from previous challenge 
models (Dames et al. 2014; Dietert et al. 2014; Reppe et al. 
2009). Under challenged conditions and independently of 
the type of challenge (PBS or S. aureus), mCLCA5 strongly 
decreased both on mRNA and protein levels at 24 h after 
challenge. Interestingly, after 48 h, the mCLCA5 protein 
signal reappears, possibly due to the epithelium remaining 
intact in these two models. While mCLCA5 mRNA expres-
sion and number of mCLCA5-positive cells decreased, the 
overall number and cell type composition of club cells and 
mucus cells, the major expressing cell types of mCLCA5, 
Fig. 5  Species-specific differences in expression patterns of 
mCLCA5 and its human and porcine orthologs. Murine (n = 4), 
human (n = 2) and porcine (n = 3) lung tissues were investigated 
by immunohistochemistry. a–c A species-specific distribution pattern 
in the submucosal glands (blue lines) was observed, and all species 
investigated had mCLCA5-, hCLCA2- or pCLCA2-positive cells, 
respectively, in the epithelial cells of these SMGs (d1, e1, f1, left pic-
ture). However, only the mouse had mCLCA5-positive cells in this 
specific location within the bronchial epithelium (d2, e2, f2, right pic-
ture). Bar 40 µm
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remained constant, pointing toward a selective transcrip-
tional regulation of mCLCA5 with subsequent loss of the 
protein. Secretory processes by club cells and mucus cells 
which have been observed under challenged conditions 
(Davis and Dickey 2008; Evans et al. 2004; Pack et al. 1980; 
Reader et al. 2003; Reynolds and Malkinson 2010) may have 
contributed to the reduction of mCLCA5 on the protein level.
Under conditions of challenge, the downregulation of 
specific proteins involved in cellular differentiation is a 
known phenomenon of cells reacting to a specific type of 
challenge (Das et al. 2011; Zheng et al. 2013) which is con-
sistent with our findings and the proposed role of mCLCA5 
in cellular differentiation.
A similar effect on the mCLCA5 protein level was seen 
after infections with S. pneumoniae or influenza virus 
where a gradual reduction of mCLCA5-positive cells was 
observed over time without reappearance, possibly due to 
the initiated epithelial cell damage and death inflicted by 
these two pathogens. However, we cannot exclude that 
other, more specific factors may have contributed to the 
loss of mCLCA5 expression under the challenges used.
In a recent study comparing IL-13-challenged mice 
with PBS-treated controls, mCLCA5 protein was found 
in airway mucus cells, interpreted as a de novo expres-
sion (Mundhenk et al. 2012). However, mCLCA5 expres-
sion level and pattern in naive mice were not assessed in 
that study which would explain the fact that no differen-
tial upregulation of mCLCA5 mRNA was seen under chal-
lenged conditions (Mundhenk et al. 2012).
The murine lung, including the two niches that selec-
tively express mCLCA5, differs from the lungs of other 
species in several anatomical and functional aspects. 
Murine SMGs are restricted to the larynx and the proximal 
trachea, whereas in humans and pigs, SMGs occur along 
the entire cartilaginous airways (Liu and Engelhardt 2008; 
Lynch and Engelhardt 2014; Rawlins and Hogan 2005; 
Rock et al. 2010; Suarez et al. 2012). The murine proxi-
mal airway epithelium predominantly consists of club cells, 
the principal secretory cell type (Liu et al. 2006; Rawlins 
and Hogan 2006; Reynolds and Malkinson 2010; Rock and 
Hogan 2011), followed by ciliated and fewer mucus cells 
(Pack et al. 1980; Wong et al. 2009). In contrast, ciliated 
and basal cells dominate in the human lung with much less 
secretory goblet cells (Rawlins and Hogan 2006; Rock et al. 
2010; Wong et al. 2009). It is important to note that bron-
chial club cells, the major mCLCA5-expressing cell type 
in the mouse, do not exist in humans (Suarez et al. 2012). 
Furthermore, basal cells can only be found in the murine 
trachea and proximal cartilaginous airways (Rawlins and 
Hogan 2006; Rock et al. 2009), whereas in humans, they 
extend down to small bronchi (Fox 2007; Suarez et al. 
2012; Wetzels et al. 1992). Based on these species-specific 
differences in airway anatomy and the suspected redundant 
functions of murine CLCA homologs (Patel et al. 2009), 
mice may not be the most suitable model for studying 
CLCA gene products in mucus cell metaplasia.
We therefore tested whether other species also express 
mCLCA5 orthologs in these specific niches of the respira-
tory tract. Specifically, we examined the protein expression 
patterns of hCLCA2 and pCLCA2, the direct orthologs to 
the murine mCLCA5, in human and porcine lungs. Inter-
estingly, only very few human and some porcine SMG 
cells but no bronchial epithelial cells were found to express 
hCLCA2 or pCLCA2, respectively. It is tempting to specu-
late that this unique niche of mCLCA5-expressing cells in 
murine bronchial epithelium compensates for the lack of 
SMGs in the lower segments of murine airways.
The lack of hCLCA2 and pCLCA2 expression in the 
bronchial epithelium may point toward a species-specific 
function and is in line with the observation that hCLCA2 
is not upregulated under mucus cell metaplasia, in contrast 
to its murine ortholog mCLCA5 (Alevy et al. 2012). Con-
troversially, the similarity of mCLCA5 ortholog expression 
pattern between humans and pigs supports the notion that 
CLCA genes may be more closely related to the human 
than to the murine species as one would expect from the 
degree of sequence similarities (Plog et al. 2009, 2012a, b). 
The pig may thus become the preferred model in studying 
mucus cell metaplasia.
In summary, our results yielded several surprising 
observations on the distribution of mCLCA5 in the mouse 
lung and its human and porcine orthologs, hCLCA2 and 
pCLCA2. First, naive mice express mCLCA5 in very dis-
tinct niches of their bronchial epithelium and in epithelial 
cells of the SMGs. Second, under conditions of challenge, 
including instillation of PBS and infection with S. aureus, 
S. pneumoniae or influenza virus, mCLCA5 mRNA and 
protein expression strongly declined with protein reappear-
ance only after challenges without epithelial cell damage. 
Third, the mCLCA5 orthologs, hCLCA2 and pCLCA2, are 
not expressed by bronchial epithelial cells in human and 
porcine lungs, respectively. Here, the orthologous proteins 
are present in SMG epithelial cells only, which, however, 
decorate the entire bronchial branchings. We speculate that 
the lack of these glands in most segments of the murine 
bronchial tree is compensated by additional mCLCA5 
expression in a highly select area of the murine bronchial 
epithelium. Together with the results of previous studies on 
mCLCA5 and other CLCA homologs, our results raise sev-
eral questions as to the role of these proteins in the matura-
tion and differentiation of mucus cells. An approach includ-
ing an ovalbumin challenge as the preferred model for 
studying mucus cell differentiation and mucus cell meta-
plasia in mice (Long et al. 2006; Nakanishi et al. 2001; 
Robichaud et al. 2005; Zhang and He 2010) may become 
of special interest in this issue.
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